US Stock MarketDetailed Quotes

SMMT Summit Therapeutics

Watchlist
  • 18.890
  • -0.090-0.47%
Trading Nov 19 10:40 ET
13.93BMarket Cap-82130P/E (TTM)

Summit Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Summit Therapeutics Q3 2024 Earnings Date

Currency：USDOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
--
-0.08
--
-166.67%
Analyst Rating
Strong Buy

Nov 4, 2024

Summit Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Oct 30, 20242024/Q30.000 / 0.000--
Aug 6, 20242024/Q20.000 / 0.000--
May 1, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Oct 30, 20242024/Q30.000 / 0.000--
Aug 6, 20242024/Q20.000 / 0.000--
May 1, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Summit Therapeutics Earnings Reports

  • Summit Therapeutics | 10-Q: Q3 2024 Earnings Report

    Oct 30 07:36 ET

  • Summit Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 07:43 ET

  • Summit Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 1 08:14 ET

  • Summit Therapeutics | 10-K: FY2023 Annual Report

    Feb 20 07:38 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 4, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data